PA8595301A1 - SYNTHETIC COMBINATION OF NELFINAVIR WITH FOOD - Google Patents
SYNTHETIC COMBINATION OF NELFINAVIR WITH FOODInfo
- Publication number
- PA8595301A1 PA8595301A1 PA20048595301A PA8595301A PA8595301A1 PA 8595301 A1 PA8595301 A1 PA 8595301A1 PA 20048595301 A PA20048595301 A PA 20048595301A PA 8595301 A PA8595301 A PA 8595301A PA 8595301 A1 PA8595301 A1 PA 8595301A1
- Authority
- PA
- Panama
- Prior art keywords
- nelfinavir
- food
- synthetic combination
- combination
- synthetic
- Prior art date
Links
- QAGYKUNXZHXKMR-UHFFFAOYSA-N CPD000469186 Natural products CC1=C(O)C=CC=C1C(=O)NC(C(O)CN1C(CC2CCCCC2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-UHFFFAOYSA-N 0.000 title abstract 2
- 235000013305 food Nutrition 0.000 title abstract 2
- QAGYKUNXZHXKMR-HKWSIXNMSA-N nelfinavir Chemical compound CC1=C(O)C=CC=C1C(=O)N[C@H]([C@H](O)CN1[C@@H](C[C@@H]2CCCC[C@@H]2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-HKWSIXNMSA-N 0.000 title abstract 2
- 229960000884 nelfinavir Drugs 0.000 title abstract 2
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000007813 immunodeficiency Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA INVENCION SE REFIERE A UNA COMBINACION SINERGETICA QUE COMPRENDE UNA CANTIDAD TERAPEUTICAMENTE EFICAZ DE NELFINAVIR EN UNA COMPOSICION FARMACEUTICA CON ALIMENTOS, PARA TRATAR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA (HIV) EN UN MAMIFERO.THE INVENTION REFERS TO A SYNERGETIC COMBINATION THAT INCLUDES A THERAPEUTICALLY EFFECTIVE AMOUNT OF NELFINAVIR IN A PHARMACEUTICAL COMPOSITION WITH FOODS, TO TREAT THE VIRUS OF HUMAN IMMUNODEFICIENCY (HIV) IN A MAMMER.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44644403P | 2003-02-10 | 2003-02-10 | |
US52425803P | 2003-11-21 | 2003-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8595301A1 true PA8595301A1 (en) | 2005-08-04 |
Family
ID=32853430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20048595301A PA8595301A1 (en) | 2003-02-10 | 2004-02-09 | SYNTHETIC COMBINATION OF NELFINAVIR WITH FOOD |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1605942A1 (en) |
JP (1) | JP2006517221A (en) |
AR (1) | AR043133A1 (en) |
BR (1) | BRPI0407174A (en) |
CA (1) | CA2515095A1 (en) |
CL (1) | CL2004000202A1 (en) |
MX (1) | MXPA05008425A (en) |
NL (1) | NL1025449C2 (en) |
PA (1) | PA8595301A1 (en) |
PE (1) | PE20040948A1 (en) |
TW (1) | TW200423922A (en) |
UY (1) | UY28183A1 (en) |
WO (1) | WO2004069251A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157455B2 (en) | 2003-02-10 | 2007-01-02 | Hoffmann-La Roche Inc. | 4-Aminopyrimidine-5-one derivatives |
-
2004
- 2004-01-29 WO PCT/IB2004/000313 patent/WO2004069251A1/en not_active Application Discontinuation
- 2004-01-29 BR BR0407174-3A patent/BRPI0407174A/en not_active IP Right Cessation
- 2004-01-29 CA CA002515095A patent/CA2515095A1/en not_active Abandoned
- 2004-01-29 JP JP2006502411A patent/JP2006517221A/en active Pending
- 2004-01-29 EP EP04706250A patent/EP1605942A1/en not_active Withdrawn
- 2004-01-29 MX MXPA05008425A patent/MXPA05008425A/en unknown
- 2004-02-05 CL CL200400202A patent/CL2004000202A1/en unknown
- 2004-02-09 PA PA20048595301A patent/PA8595301A1/en unknown
- 2004-02-09 AR ARP040100399A patent/AR043133A1/en unknown
- 2004-02-09 PE PE2004000146A patent/PE20040948A1/en not_active Application Discontinuation
- 2004-02-09 TW TW093102921A patent/TW200423922A/en unknown
- 2004-02-10 UY UY28183A patent/UY28183A1/en not_active Application Discontinuation
- 2004-02-10 NL NL1025449A patent/NL1025449C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CL2004000202A1 (en) | 2005-03-18 |
JP2006517221A (en) | 2006-07-20 |
EP1605942A1 (en) | 2005-12-21 |
NL1025449C2 (en) | 2005-03-15 |
UY28183A1 (en) | 2004-09-30 |
PE20040948A1 (en) | 2004-12-27 |
CA2515095A1 (en) | 2004-08-19 |
NL1025449A1 (en) | 2004-08-12 |
AR043133A1 (en) | 2005-07-20 |
TW200423922A (en) | 2004-11-16 |
BRPI0407174A (en) | 2006-02-07 |
WO2004069251A1 (en) | 2004-08-19 |
MXPA05008425A (en) | 2005-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2019000185A (en) | A SOLID PHARMACEUTICAL DOSAGE FORMULATION | |
CL2007003686A1 (en) | COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION. | |
BRPI0606145A2 (en) | breakthrough-resistant sustained release dosage forms | |
CL2008001983A1 (en) | COMPOUNDS DERIVED FROM FTALAZINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT VASCULAR DISEASES, SEPTIC SHOCK, ISCHEMICAL INJURIES, NEUROTOXICITY, HEMORRAGICAL SHOCK, VIRAL INFECTIONS, AMONG OTHERS. | |
CL2007003685A1 (en) | COMPOUNDS DERIVED FROM INDOL WITH A UNITED RING IN POSITIONS 4 AND 5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A VIRAL INFECTION. | |
HN2005000255A (en) | USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
GT200600260A (en) | BENZAMIDA DERIVATIVES AND USES RELATED TO THE SAME | |
CL2008000910A1 (en) | Fusion protein comprising a protein that cuts the beta amyloid peptide; pharmaceutical composition that includes it, and its use to prevent and / or treat diseases related to beta amyloid peptide. | |
AR112015A1 (en) | SOLID COMPOSITIONS FOR ORAL ADMINISTRATION | |
EA200701820A1 (en) | APPLICATION OF DIOSMETIN COMPOUNDS IN THE TREATMENT AND PREVENTION OF THROMBOTIC PATHOLOGIES | |
DK1809661T3 (en) | Human interferon-beta-mutein | |
PL1845957T3 (en) | Method for producing a drug extract that contains hydroxystilbenes | |
CL2007002671A1 (en) | COMPOUNDS DERIVED FROM OCTAHIDRO-PIRROLO [3,4-C] PIRROL; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE OF THE COMPOUND IN THE TREATMENT OF HIV, AIDS OR ARC. | |
NO20073026L (en) | 2-Alkoxy-3,4,5-trihydroxyalkylamides, preparation and compositions thereof, and use thereof | |
PA8604401A1 (en) | ARIL-HETEROAROMATIC PRODUCTS, COMPOSITIONS THAT CONTAIN THEM AND ITS USE. | |
CL2007001826A1 (en) | Compounds derived from 2- (amino-substituted) -benzothiazol-sulfonamide, protease inhibitors, in particular, hiv protease inhibitors; pharmaceutical composition; and use to treat or combat an infection or disease associated with the infection of a multi-drug resistant retrovirus. | |
AR052960A1 (en) | COMPOSITIONS FOR THE ORAL TRANSMUCTION TRANSMISSION OF METFORMIN | |
ATE420089T1 (en) | SUBSTITUTED AZACHINAZOLINES WITH ANTIVIRAL EFFECT | |
PA8806501A1 (en) | TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE | |
PA8571901A1 (en) | NEW PHARMACEUTICAL COMPOSITION | |
PA8595301A1 (en) | SYNTHETIC COMBINATION OF NELFINAVIR WITH FOOD | |
PA8802001A1 (en) | NOVEDOUS ANTIRETROVIRAL COMBINATION | |
EA200870565A1 (en) | 2-ALKOXI-3,4,5-TRIHYDROXIALKYLAMIDOBENZEZEPINA, THEIR RECEIVING, THEIR COMPOSITIONS AND APPLICATION | |
EA201992151A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY | |
TR201914034A2 (en) | USAGE OF SCHISANDRIN B AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE |